Bio-Rad Labs Proxy: Executive Pay & Equity Awards Detailed
Ticker: BIO-B · Form: DEF 14A · Filed: Mar 26, 2025 · CIK: 12208
| Field | Detail |
|---|---|
| Company | Bio-Rad Laboratories, Inc. (BIO-B) |
| Form Type | DEF 14A |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, shareholder-meeting
Related Tickers: BIO
TL;DR
BIO proxy out: exec pay details, equity awards for 2024, shareholder votes coming up.
AI Summary
Bio-Rad Laboratories, Inc. filed its DEF 14A proxy statement on March 26, 2025, detailing executive compensation and annual meeting matters for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to both principal executive officers (PEO) and non-principal executive officers (Non-PEO), as well as the change in fair value of outstanding equity awards.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting corporate governance and investor confidence.
Risk Assessment
Risk Level: low — This is a routine proxy filing detailing executive compensation and annual meeting information, with no immediate financial risks indicated.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the executive compensation details.)
- 20250326 — Filing Date (Date the DEF 14A was filed with the SEC.)
Key Players & Entities
- BIO-RAD LABORATORIES, INC. (company) — Filer of the DEF 14A
- 1000 ALFRED NOBEL DRIVE, HERCULES, CA 94547 (address) — Company's business and mailing address
- 0001308179-25-000235 (filing_id) — Accession number for the filing
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used to solicit proxies from shareholders and provides detailed information about matters to be voted on at an annual or special meeting of shareholders, including executive compensation, director elections, and other corporate governance issues.
What specific compensation elements are detailed for Bio-Rad's executives in this filing?
The filing details equity awards granted to Principal Executive Officers (PEO) and Non-Principal Executive Officers (Non-PEO), including information on outstanding and unvested equity awards and changes in their fair value.
What is the fiscal year end for Bio-Rad Laboratories, Inc. as stated in the filing?
The fiscal year end for Bio-Rad Laboratories, Inc. is December 31st, as indicated by the 'FISCAL YEAR END: 1231' and the reporting periods for compensation data.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on March 26, 2025.
What is the SIC code for Bio-Rad Laboratories, Inc.?
The Standard Industrial Classification (SIC) code for Bio-Rad Laboratories, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 26, 2025 regarding BIO-RAD LABORATORIES, INC. (BIO-B).